CI_with has_DoseForm has_Ingredient has_MoA has_PE may_prevent may_treat drug associated with AE Cholestasis, Extrahepatic [Disease/Finding] Coronary Artery Disease [Disease/Finding] Diarrhea [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Enterocolitis, Pseudomembranous [Disease/Finding] Hypercholesterolemia [Disease/Finding] Hyperlipoproteinemias [Disease/Finding] Intestinal Obstruction [Disease/Finding] Hypertriglyceridemia [Disease/Finding] Cholestyramine Resin [Chemical/Ingredient] Decreased Cholesterol Absorption [PE] [CV350] ANTILIPEMIC AGENTS Oral Suspension [Dose Form] CHOLESTYRAMINE CHOLESTYRAMINE 4GM/5GM PWDR [VA Product] CHOLESTYRAMINE 4GM/5GM PWDR VA Product Cholestyramine Resin 66.7 MG/ML Oral Suspension 848943 <VANDF_Record>50.68^6114^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>6114</VA_IEN><VA_Status>Active/Master</VA_Status> 4 <Product_Component>CHOLESTYRAMINE</Product_Component><Strength>4</Strength><Unit>GM/5GM</Unit><VA.IEN>1413</VA.IEN> 0 N0000154646 CHOLESTYRAMINE 4GM/5GM (LIGHT) ORAL PWD CHOLESTYRAMINE POWDER 考来烯胺散 GM/5GM C37254 C0782175 4006635 Binding Activity [MoA] pancreatitis AE headache AE gastrointestinal hemorrhage AE dyspepsia AE vertigo AE edema AE nausea AE vomiting AE constipation AE gastric ulcer AE osteoporosis AE cholelithiasis AE heartburn AE eructation AE stomach ache AE steatorrhea AE malabsorption syndrome AE CHOLESTYRAMINE 4GM/5GM PWDR [VA Product] 4 <Product_Component>CHOLESTYRAMINE</Product_Component><Strength>4</Strength><Unit>GM/5GM</Unit><VA.IEN>1413</VA.IEN> 0 CHOLESTYRAMINE 4GM/5GM PWDR VA Product C37254 N0000154646 考来烯胺散 C0782175 GM/5GM Cholestyramine Resin 66.7 MG/ML Oral Suspension CHOLESTYRAMINE 4GM/5GM (LIGHT) ORAL PWD <VANDF_Record>50.68^6114^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>6114</VA_IEN><VA_Status>Active/Master</VA_Status> 848943 CHOLESTYRAMINE POWDER 4006635